The first POINT Biopharma Global trade was made in Q3 2021.
Since then Ken Griffin bought shares three more times and sold shares on six occasions. The investor completely sold their stake between Q4 2022 and Q4 2023.
Avg closing price
Price range
Sold -2.16 Million shares
Q4 2023
Avg closing price
$12.62
Price range
$6.68
-
$13.68
Sold 12.1% shares (-298 Thousand shares)
Q3 2023
Avg closing price
$8.31
Price range
$6.67
-
$9.71
Sold 23.0% shares (-733 Thousand shares)
Q2 2023
Avg closing price
$8.82
Price range
$6.86
-
$10.86
Sold 2.0% shares (-63.6 Thousand shares)
Q1 2023
Avg closing price
$7.42
Price range
$6.78
-
$8.10
Sold 11.6% shares (-428 Thousand shares)
Q4 2022
Avg closing price
$7.42
Price range
$5.72
-
$9.78
Increased shares by 59.3% (+1.37 Million shares)
Q3 2022
Avg closing price
$8.49
Price range
$7.24
-
$10.31
Sold 7.3% shares (-183 Thousand shares)
Q2 2022
Avg closing price
$7.65
Price range
$5.60
-
$9.50
Increased shares by 1.5% (+37.4 Thousand shares)
Q1 2022
Avg closing price
$6.35
Price range
$5.46
-
$8.13
Increased shares by 0.4% (+9.44 Thousand shares)
Q4 2021